Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
ANNA TSAKIRI
🇬🇷
Greece
Country
🇬🇷
Greece
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Simvastatin as an add-on Treatment to Copaxone for the Treatment of Relapsing Multiple Sclerosis
Phase 3
Withdrawn
Conditions
Relapsing Remitting Multiple Sclerosis
Interventions
Drug: placebo
Drug: Simvastatin
Subscribe
First Posted Date
2007-01-31
Last Posted Date
2014-02-20
Lead Sponsor
Anna Tsakiri
Registration Number
NCT00429442
Locations
🇩🇰
Department of Neurology, Glostrup University Hospital, Glostrup, Denmark
Subscribe
Prev
1
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy